Literature DB >> 29184978

Chronic infection and infected non-union of the long bones in paediatric patients: preliminary results of bone versus beta-tricalcium phosphate grafting after induced membrane formation.

Marie Rousset1, Marjolaine Walle1, Ludivine Cambou1, Mounira Mansour1, Antoine Samba1, Bruno Pereira2, Ismat Ghanem3, Federico Canavese4.   

Abstract

PURPOSE: Chronic infection (CO) and infected non-union of the long bones are relatively rare conditions in paediatric patients. Large bone defects secondary to these conditions can be managed with the induced membrane technique. The technique requires grafting of the bone void, although it is not yet established what bone substitute is the best option. The aim of this work was to evaluate the outcome and efficacy of treatment in children with CO and infected non-union of the long bones using the induced membrane technique and bone (BG) versus beta-tricalcium phosphate (BTP) grafting.
METHODS: Eight skeletally immature patients with CO and infected non-union of the long bones were treated surgically between 2010 and 2017 by a combination of resection of necrotic infected bone, debridement of surrounding soft tissue, osteosynthesis using a stable internal fixation when needed, and application of antibiotic-laden cement (ALC) spacer inducing new membrane before final bone reconstruction with bone substitutes: BTP in five cases, BG (allograft and/or autologous graft) in three cases. A second surgical step, once inflammatory markers had normalized, consisted of ALC spacer removal, application of BG or BTP graft and concomitant stable osteosynthesis, if needed, if this had not been done during the first surgical stage. All the patients underwent clinical, laboratory and imaging evaluation before and after surgery. Antibiotics were adjusted according to culture and sensitivity.
RESULTS: Mean patient age at time of diagnosis was 13 ± four years (range, 4-16) and all had at least a 12-month follow-up (range 12-60). Estimated time for induced membrane formation was significantly shorter in patients treated with BTP compared with BG: 3±1 vs. 10±2 (p = 0.02). This result was confirmed by multivariate analysis (p = 0.044) taking into account adjustment for age of patients and time after initial surgery. Time of final union was about 5.5 ± 4.1 months (range 2-66). At the last follow-up visit, bone had healed and all the patients had resumed daily living and sports activities.
CONCLUSION: The induced membrane technique with BG or BTP graft can achieve bone healing in large bone defects secondary to CO and infected non-union in children and adolescents. The choice of bone substitute is important. Our preliminary results show graft integration and bone healing can be expected sooner if BTP is used as bone void filler.

Entities:  

Keywords:  Beta-tricalcium phosphate; Bone graft; Bone loss; Children; Chronic osteomyelitis; Induced membrane

Mesh:

Substances:

Year:  2017        PMID: 29184978     DOI: 10.1007/s00264-017-3693-x

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  32 in total

1.  Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis.

Authors:  Lars Helbig; Hans Georg Simank; Helga Lorenz; Cornelia Putz; Christoph Wölfl; Arnold J Suda; Arash Moghaddam; Gerhard Schmidmaier; Thorsten Guehring
Journal:  Int Orthop       Date:  2013-10-30       Impact factor: 3.075

2.  Is the Induced-membrane Technique Successful for Limb Reconstruction After Resecting Large Bone Tumors in Children?

Authors:  Frank Fitoussi; Brice Ilharreborde
Journal:  Clin Orthop Relat Res       Date:  2015-01-30       Impact factor: 4.176

3.  Treatment of posttraumatic bone defects by the induced membrane technique.

Authors:  C Karger; T Kishi; L Schneider; F Fitoussi; A-C Masquelet
Journal:  Orthop Traumatol Surg Res       Date:  2012-01-12       Impact factor: 2.256

4.  Chronic osteomyelitis in children: treatment by intramedullary reaming and antibiotic-impregnated cement rods.

Authors:  Elhanan Bar-On; Daniel M Weigl; Noam Bor; Tali Becker; Kalman Katz; Eyal Mercado; Gilat Livni
Journal:  J Pediatr Orthop       Date:  2010 Jul-Aug       Impact factor: 2.324

Review 5.  Managing large bone defects in children: a systematic review of the 'induced membrane technique'.

Authors:  Ilaria Morelli; Lorenzo Drago; David A George; Delia Romanò; Carlo L Romanò
Journal:  J Pediatr Orthop B       Date:  2018-09       Impact factor: 1.041

6.  Intramedullary infections treated with antibiotic cement rods: preliminary results in nine cases.

Authors:  Dror Paley; John E Herzenberg
Journal:  J Orthop Trauma       Date:  2002 Nov-Dec       Impact factor: 2.512

7.  Calcium sulfate as bone graft substitute in the treatment of osseous bone defects, a prospective study.

Authors:  Yashavantha Kumar C; Nalini K B; Jagdish Menon; Dilip Kumar Patro; Banerji B H
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors.

Authors:  Akira Ogose; Tetsuo Hotta; Hiroyuki Kawashima; Naoki Kondo; Wenguang Gu; Takeshi Kamura; Naoto Endo
Journal:  J Biomed Mater Res B Appl Biomater       Date:  2005-01-15       Impact factor: 3.368

9.  The Masquelet technique for membrane induction and the healing of ovine critical sized segmental defects.

Authors:  Chris Christou; Rema A Oliver; Yan Yu; William R Walsh
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

10.  Treatment of chronic orthopaedic infection.

Authors:  Heinz Winkler
Journal:  EFORT Open Rev       Date:  2017-05-11
View more
  8 in total

1.  Altering polymerization temperature of antibiotic-laden cement can increase porosity and subsequent antibiotic elution.

Authors:  Jeffrey Sundblad; Mary Nixon; Nancy Jackson; Rahul Vaidya; David Markel
Journal:  Int Orthop       Date:  2018-09-15       Impact factor: 3.075

2.  One-stage surgery for adult chronic osteomyelitis: concomitant use of antibiotic-loaded calcium sulphate and bone marrow aspirate.

Authors:  Ahmed Abdel Badie; Mohamed S Arafa
Journal:  Int Orthop       Date:  2018-07-19       Impact factor: 3.075

3.  Bridge plating with decortication, autologous bone graft, and tight closure: a "stepwise surgical diamond concept" for treatment of nonunion in a series of fifty five patients.

Authors:  Ali Hassan Chamseddine; Mark E Mouchantaf; Kinan F Freiha; Ali H Asfour; Abbas A Dib; Hassan M Wardani; Ali M Bazzal; Georgio E Nahed
Journal:  Int Orthop       Date:  2022-03-20       Impact factor: 3.479

4.  Acute hematogenous osteomyelitis in children: Management of pandiaphysitis with extensive bone destruction: A case series of thirteen child.

Authors:  Mohamed Zairi; Ahmed Amin Mohseni; Ahmed Msakni; Chaker Jaber; Kacem Mensia; Walid Saied; Sami Bouchoucha; Rim Boussetta; Mohamed Nabil Nessib
Journal:  Ann Med Surg (Lond)       Date:  2022-09-08

5.  Induced membrane technique for the treatment of severe acute tibial bone loss: preliminary experience at medium-term follow-up.

Authors:  Mario Ronga; Mario Cherubino; Katia Corona; Alessandro Fagetti; Barbara Bertani; Luigi Valdatta; Redento Mora; Paolo Cherubino
Journal:  Int Orthop       Date:  2018-10-02       Impact factor: 3.075

6.  Masquelet induced membrane technique for treatment of rat chronic osteomyelitis.

Authors:  Tao Cui; Junpeng Li; Ping Zhen; Qiuming Gao; Xiaohai Fan; Chuangbing Li
Journal:  Exp Ther Med       Date:  2018-08-06       Impact factor: 2.447

Review 7.  Evolution and Development of Ilizarov Technique in the Treatment of Infected Long Bone Nonunion with or without Bone Defects.

Authors:  Jun Li; Mingxin Li; Wenzhao Wang; Bohua Li; Lei Liu
Journal:  Orthop Surg       Date:  2022-03-27       Impact factor: 2.279

8.  Adding a Fibular Strut Allograft to Intramedullary Nail and Cancellous Autograft During Stage II of the Masquelet Technique for Segmental Femur Defects: A Technique Tip.

Authors:  Omar Ramos; Michael Mariorenzi; Joey P Johnson; Roman A Hayda
Journal:  J Am Acad Orthop Surg Glob Res Rev       Date:  2020-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.